Amedisys Stock-Based Compensation 2010-2025 | AMED
Amedisys stock-based compensation from 2010 to 2025. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
Amedisys Annual Stock-Based Compensation
(Millions of US $) |
| 2024 |
$31 |
| 2023 |
$29 |
| 2022 |
$17 |
| 2021 |
$24 |
| 2020 |
$27 |
| 2019 |
$25 |
| 2018 |
$18 |
| 2017 |
$16 |
| 2016 |
$16 |
| 2015 |
$12 |
| 2014 |
$6 |
| 2013 |
$7 |
| 2012 |
$7 |
| 2011 |
$8 |
| 2010 |
$11 |
| 2009 |
$8 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$3.132B |
$2.348B |
|
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
|
